You must be signed in to set price alerts.
Pinned straw:
Likely full approval for Eisai’s Leqembi next month after FDA decision this Friday. Predicted CMS coverage. Anticipated sales of US $7billion by 2030.
https://endpts.com/fda-signals-likely-full-approval-for-eisais-new-alzheimers-drug-ahead-of-fridays-adcomm/
From Eisai's presentation a couple of months ago. Cogstate's Healthcare division is at the top of the Leqembi treatment funnel.
There is a trade pending processing for this company.
Trades cannot be saved or cancelled while they are pending-processing.